These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10563423)

  • 1. Epidemiology of primary CNS lymphoma.
    Schabet M
    J Neurooncol; 1999 Jul; 43(3):199-201. PubMed ID: 10563423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
    Mahale P; Shiels MS; Lynch CF; Engels EA
    Am J Transplant; 2018 Feb; 18(2):453-461. PubMed ID: 28805292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
    O'Neill BP; Decker PA; Tieu C; Cerhan JR
    Am J Hematol; 2013 Dec; 88(12):997-1000. PubMed ID: 23873804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
    Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
    Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003.
    Haldorsen IS; Kråkenes J; Goplen AK; Dunlop O; Mella O; Espeland A
    BMC Cancer; 2008 Aug; 8():225. PubMed ID: 18684320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
    Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
    Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas.
    Nakamura M; Shimada K; Ishida E; Konishi N
    Histol Histopathol; 2004 Jan; 19(1):211-9. PubMed ID: 14702189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
    Chaturvedi AK; Mbulaiteye SM; Engels EA
    Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
    Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
    Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. StatBite: Lymphoma incidence in HIV patients vs. general population.
    J Natl Cancer Inst; 2010 Jul; 102(14):1003. PubMed ID: 20616355
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired immunodeficiency syndrome-related systemic non-Hodgkin's lymphoma.
    Bower M
    Br J Haematol; 2001 Mar; 112(4):863-73. PubMed ID: 11298581
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary non-Hodgkin's malignant lymphoma of the central nervous system].
    Monjour A; Poisson M; Kujas M; Delattre JY
    Rev Neurol (Paris); 1992; 148(10):589-600. PubMed ID: 1295053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas.
    Cingolani A; Gastaldi R; Fassone L; Pierconti F; Giancola ML; Martini M; De Luca A; Ammassari A; Mazzone C; Pescarmona E; Gaidano G; Larocca LM; Antinori A
    J Clin Oncol; 2000 Oct; 18(19):3325-30. PubMed ID: 11013271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.
    Dandachi D; Ostrom QT; Chong I; Serpa JA; Giordano TP; Kruchko C; Barnholtz-Sloan JS; Fowler N; Colen RR; Morón FE
    Cancer Causes Control; 2019 May; 30(5):477-488. PubMed ID: 30888569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system lymphomas--an update.
    Jellinger KA; Paulus W
    J Cancer Res Clin Oncol; 1992; 119(1):7-27. PubMed ID: 1400570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
    International Collaboration on HIV and Cancer
    J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.